Cano Health, Inc.

CANOQ Healthcare Medical Care Facilities

Cano Health, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $3.1 billion, up 14.6% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.

0.24 0.00 0.00%
Market cap
$6.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
3/9
Altman Z
−2.84
Beneish M
−7.85
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 65.84%

Capital & Financial Ratios $m

Market Cap 6.62
Revenue 2,955.27
Net Income (1,516.52)
Free Cash Flow (163.37)
Net Debt (173.55)
Current Ratio 0.96 (below 1: weak)
Debt/Equity (0.01) (negative: negative equity)
P/E ratio 0.00
Fwd P/E —
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 75.48% (at or above 15%: strong)
Next Y EPS Growth (76.26%) (below 0%: weak)
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2021 2022 2023 Q'24
Cash 163 27 94 179
Receivables 133 234 76 54
Inventory — — — —
Other — — — —
317 341 183 255
2021 2022 2023 Q'24
Payables 81 106 108 60
ST’ Debt 17 46 48 —
Other 40 24 76 7
161 208 1,415 267

Compound Annual Growth %

10y 5y 3y
Sales — — 55.68%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 684 — — — —
’23 867 767 788 716 3,138
’22 704 689 665 680 2,739
’21 275 344 499 492 1,609
’20 — 171 263 397 832
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (49) — — — —
’23 (29) (15) (40) (44) (129)
’22 (37) (45) (2) (62) (146)
’21 (15) (43) (36) (24) (118)
’20 — (13) (8) 12 (9)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (50) — — — —
’23 (35) (22) (47) (45) (148)
’22 (45) (58) (21) (73) (196)
’21 (17) (48) (52) (35) (152)
’20 — (17) (13) 9 (21)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (91.10) — — — —
’23 (12.00) (51.00) (91.87) (5.85) (242.60)
’22 0.00 (3.00) (23.00) (61.00) (95.00)
’21 (0.21) (7.00) (9.00) (12.00) (28.00)
’20 (0.02) 0.00 0.00 (0.33) (102.99)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Trend 2024e 2025e 2026e
Price, $
Price, $ Low — — — — — — 500.00 787.00 98.01 5.13

Analyst estimates 2024–2026

Powerpack
High — — — — — — 1,470.00 1,743.00 975.00 190.00
People
People Employees — — — — — — — — 4,365 2,700
Revenue/emp, $m — — — — — 0.00 0.00 0.00 0.63 1.16
Income, $m
Income, $m Revenue — — — — — 361 832 1,609 2,739 3,138
Gross margin, % — — — — — 100.00 100.00 100.00 100.00 100.00
EBT — — — — — (20) (70) (117) (426) (1,101)
EBT margin, % — — — — — (5.47) (8.47) (7.25) (15.56) (35.08)
Net income — — — 0 — (20) (71) (117) (428) (1,099)
Depreciation — — — — — 7 25 54 417 635
Per share, $
Per share, $ Revenue — — — — — 0.00 0.00 943.86 1,249.68 1,139.30
Earnings — — — — — (0.01) (4.12) (11.00) (95.00) (111.30)
Cash flow — — — — — 0.00 0.00 (69.22) (66.77) (46.86)
Capex — — — — — 0.00 0.00 (20.15) (22.60) (6.98)
Free cash flow — — — — — 0.00 0.00 (89.37) (89.37) (53.84)
Book value — — — — — 0.00 0.00 468.34 225.52 (194.26)
Shares, m — — — — — 0 0 2 2 3
Valuation, ×
Valuation, × P/E — — — — — 0.00 0.00 0.00 0.00 0.00
P/S — — — — — 0.00 0.00 0.94 0.09 0.00
P/B — — — — — 0.00 2,330.71 1.90 0.50 0.00
EV/Sales — — — — — 0.00 0.00 1.42 0.47 (0.01)
EV/FCF — — — — — 0.00 (5,450.15) (15.03) (6.54) 0.16
Cash, $m
Cash, $m Operating cash flow — — — — — (15) (9) (118) (146) (129)
Capex — — — — — (9) (12) (34) (50) (19)
Free cash flow — — — — — (25) (21) (152) (196) (148)
Balance, $m
Balance, $m Working capital — — — — — 0 44 156 132 (1,233)
Total debt — — — — — — 499 935 1,063 55
Net debt — — — — — — 465 772 1,036 (39)
Shareholders’ equity — — — — — 0 50 799 494 (535)
Returns, %
Returns, % ROA — — — — — (86,754.39) (23.14) (1.31) (10.18) (40.40)
ROIC — — — — — 0.00 (0.03) (5.38) (17.84) 0.00
ROE — — — — — (79.12) (286.43) (4.25) (32.06) 2,919.11
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2023 · latest quarter Mar 2024

Charts ten years each

Cano Health, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $8.4M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
CANOQ Cano Health, Inc. $6.6M — (loss-making) — −21.05% (below 0%: shrinking) n/m −43.68% (below 0%: shrinking) 100.00% (16.23%)
MODVQ ModivCare Inc. $6.2M — (loss-making) — (loss-making) −3.18% (below 0%: shrinking) n/m −3,767.70% (below 0%: shrinking) 14.06% (1.78%) Compare
BMGL Basel Medical Group Ltd $6.2M — — — — — — — Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
NIVF NewGenIvf Group Limited $2.3M — — — — — — — Compare
Median of peers $7.3M — — +28.44% — −169.32% 23.76% (1.51%)

All 55 Medical Care Facilities stocks →

Cano Health, Inc. (CANOQ) key facts

  • Strength: Cano Health, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $3.1 billion, up 14.6% from fiscal 2022.
  • Cano Health, Inc. (CANOQ) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of June 28, 2024, CANOQ traded at $0.24, a market capitalization of $6.6 million.
  • Return on equity was 2,919.1% and debt-to-equity -0.01.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −2.84 (distress zone) for fiscal 2023.

Source: company filings (standardised) and stockrow calculations.

Cano Health, Inc. (CANOQ) Latest News

stockrow.com/CANOQ · Data as of Mar 31, 2024 · For information only; not investment advice. · © 2026 stockrow.com